Singapore Stock Market News
Religare Health Trust - Fairly priced
StockFanatic
Publish date: Thu, 19 Nov 2015, 12:35 PM
StockFanatic
0 10,453
Welcome to Stockfanatic Singapore stock market and regional market news. This is a platform to share Singapore stock market and regional news to investors / man in the street. Investors can also look forward to analyst reports and brokers recommendations. Stockfanatic's Singapore stock market and regional news blog, home of investors one stop news station.
Strong outlook is priced in
We maintain our HOLD recommendation with TP of S$0.97. While we are positive on Religare Health Trust (RHT)'s expansion plans and exposure to the growing demand for healthcare services in India, we believe these attractive attributes have largely been priced in.
Development and asset enhancement initiatives to drive future growth
Looking ahead, we expect RHT to continue to deliver decent organic growth on the back of a robust outlook in the Indian healthcare sector and steady increase in average revenue per operating bed (ARPOB).
Inorganic initiatives include
(i) ongoing development projects at BG Road and Ludhiana will add another 279 beds (investment value of S$48.2m) by FY17, and
(ii) planned asset enhancement initiatives at various clinical establishments, adding 292 beds (investment cost of c.S$20m) over FY16-17.
Low gearing
RHT has significant balance sheet headroom, with gearing at only 12.1% as at end-Sept 2015. This is among the lowest in the S-REIT/property business trust space. This would allow RHT to easily support its expansion plans and/or pursue accretive acquisitions.
| Daily Chart |
Valuation:
We maintain our DDM-based TP of S$0.97. Given limited upside to our TP, we reiterate our HOLD recommendation.
Key Risks to Our View:
The key risk to our neutral stance is stronger than expected earnings and/or INR. Additional upside could also arise from acquisitions. (Read Report)
Source : DBS Group Research
More articles on Singapore Stock Market News
Market Commentary: Record highs on trade, vaccine developments
Created by StockFanatic | Aug 26, 2020
Market Commentary: Record highs on trade, vaccine developments
Created by StockFanatic | Aug 26, 2020
Market Commentary: Data help US market end week on a high note
Created by StockFanatic | Aug 24, 2020
Market Commentary: Data help US market end week on a high note
Created by StockFanatic | Aug 24, 2020
Market Commentary: And they are back, with S&P within inches of record high close
Created by StockFanatic | Aug 13, 2020
Market Commentary: And they are back, with S&P within inches of record high close
Created by StockFanatic | Aug 13, 2020
Market Commentary: US negotiations over stimulus continue amid diplomatic tensions
Created by StockFanatic | Aug 11, 2020
Market Commentary: US negotiations over stimulus continue amid diplomatic tensions
Created by StockFanatic | Aug 11, 2020
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
New Update. Discover investment communities that resonate with your ideas
Trade Confidently & Analyze Charts Conveniently - Download VCPlus IOS & Android App Now!
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
DBS Shares’ 43% Rally Seen Having More Legs as Wealth Fees Rise
3
CEO Morning Brief
Singapore Post Shares Slide After CEO Fired Over Whistleblower Report
4
5
Johor house best buy
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
